• The Boston Globe, Monday, May 21, 2007 11:15 AM

Hologic, a leading provider of mammography equipment, has agreed to buy Cytyc, whose flagship product is a Pap test for cervical cancer, creating a women's healthcare powerhouse. Hologic will pay $6.2 billion in cash and stock.

Hologic has a 55% share of the mammography equipment market, and Cytyc offers a radiation treatment for breast cancer. By combining forces and brands, they will be able to better target obstetrics and gynecology specialists, oncologists and other doctors, offering a complete suite of preventative diagnostic tests, executives at the two companies say.

The companies said the deal is expected to generate about $25 million in cost savings through combined sales efforts, shared administrative services and other efficiencies.

Read the whole story at The Boston Globe »